InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by GERSHWIND ERIK, Président. Officer active across 1 company, notably MSC Industrial Direct Co INC. Cumulatively, 10 reports have been published. History available since 17 October 2021. The latest transaction was filed on 16 November 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
84,059 shares@ US$58.900.075% mcap50.0% of flowClass A Common Stock, $0.001 par valueSEC:0001003078-21-000244:0
84,059 shares@ US$58.900.075% mcap100.0% of flowClass A Common Stock, $0.001 par valueSEC:0001003078-21-000244
7,984 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000235
7,984 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000235:0
2,314 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000217:0
2,314 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000217
2,764 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000209:0
2,764 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000209
3,305 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000189
3,305 shares0Class A Common Stock, $0.001 par valueSEC:0001003078-21-000189:0
10 of 10 declarations
About GERSHWIND ERIK
Srdjan R. Stankovic serves as President of Acadia Pharmaceuticals Inc. In this role, he is responsible for the strategic direction of the company and the management of operations. Srdjan plays a key role in developing new therapies and optimizing the performance of the biopharmaceutical company.
